Australia markets open in 53 minutes

Australian Clinical Labs Limited (ACL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
4.6800+0.1300 (+2.86%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 927.85M
Enterprise value 1.17B
Trailing P/E 11.64
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.10
Price/book (mrq)4.47
Enterprise value/revenue 1.82
Enterprise value/EBITDA 6.28

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 336.84%
S&P500 52-week change 3-11.93%
52-week high 36.3900
52-week low 33.3900
50-day moving average 34.9794
200-day moving average 34.9056

Share statistics

Avg vol (3-month) 3350.8k
Avg vol (10-day) 3146.82k
Shares outstanding 5200.83M
Implied shares outstanding 6N/A
Float 8100.85M
% held by insiders 110.56%
% held by institutions 154.48%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.24
Forward annual dividend yield 45.33%
Trailing annual dividend rate 30.26
Trailing annual dividend yield 35.78%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 425 Mar 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin 15.40%
Operating margin (ttm)29.99%

Management effectiveness

Return on assets (ttm)30.16%
Return on equity (ttm)104.87%

Income statement

Revenue (ttm)866.8M
Revenue per share (ttm)4.81
Quarterly revenue growth (yoy)69.20%
Gross profit (ttm)520.23M
EBITDA 270.81M
Net income avi to common (ttm)133.51M
Diluted EPS (ttm)0.4100
Quarterly earnings growth (yoy)128.20%

Balance sheet

Total cash (mrq)47.33M
Total cash per share (mrq)0.24
Total debt (mrq)285.84M
Total debt/equity (mrq)137.63
Current ratio (mrq)0.83
Book value per share (mrq)1.03

Cash flow statement

Operating cash flow (ttm)228.14M
Levered free cash flow (ttm)221.82M